Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nifedipine vs Sildenafil in Secondary Raynaud's
NCT03027674Phase 1Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Aug 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Raynaud phenomenon comparing 10% nifedipine cream with 5% sildenafil cream (2 arms). Primary endpoint: Peak Systolic Velocity at 1 hour. Started Aug 2016; status: completed.
02
Drugs
nifedipinesildenafil
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT03027674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027674.